About Mark Kiel
Mark Kiel is a chief scientific officer & co-founder, director at Genomenon.
Mark Kiel first appears on SEC filings in 2015.
Experience
This experience comes from Mark Kiel's profile and from SEC filings. For roles taken from filings, the years are when the filings name Mark Kiel in the role, so the role may have started earlier or lasted longer.
Genomenon, Inc. Current
Chief Scientific Officer & Co-Founder, director
Chief Science Officer | Founder (2014 – Present)
2014 – Present · Ann Arbor, MI
Genomenon sells genetic evidence software and services to clinical labs and drug developers.
UM
University of Michigan
Post-doctoral Researcher
2009 – 2015
Key Colleagues at Startups
The people Mark Kiel works with at each company, as listed on that company's latest Form D.
Genomenon, Inc. · Form D, Jul 30, 2026
Sam Globus
Chief Operating Officer
MG
Michael Gross
Director
DG
David Gregorka
Director
Michael Klein
Chief Executive Officer and director
PG
Patricia Glaza
Director
Brian Groark
Chief Financial Officer